sb 203580 has been researched along with ammonium hydroxide in 1 studies
Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (ammonium hydroxide) | Trials (ammonium hydroxide) | Recent Studies (post-2010) (ammonium hydroxide) |
---|---|---|---|---|---|
3,489 | 4 | 1,137 | 29,152 | 577 | 9,136 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Davies, NA; Hodges, SJ; Jalan, R; Pitsillides, AA; Shawcross, DL; Stadlbauer, V; Wheeler-Jones, C; Wright, GA | 1 |
1 trial(s) available for sb 203580 and ammonium hydroxide
Article | Year |
---|---|
Ammonia impairs neutrophil phagocytic function in liver disease.
Topics: Amino Acids; Ammonia; Animals; Cell Survival; Cells, Cultured; Disease Models, Animal; Double-Blind Method; Humans; Hyperammonemia; Hyponatremia; Imidazoles; Isoproterenol; Liver Cirrhosis; Liver Diseases; Male; Middle Aged; Neutrophils; p38 Mitogen-Activated Protein Kinases; Phagocytosis; Pyridines; Rats; Rats, Sprague-Dawley; Respiratory Burst; Signal Transduction | 2008 |